BIOA
NASDAQ · Pharmaceuticals
Bioage Labs Inc
$5.34
-0.20 (-3.61%)
Open$5.31
Previous Close$5.54
Day High$5.54
Day Low$5.24
52W High$25.96
52W Low$4.81
Volume—
Avg Volume803.8K
Market Cap254.27M
P/E Ratio—
EPS$-2.39
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
+146.1% upside
Current
$5.34
$5.34
Target
$13.14
$13.14
$9.99
$13.14 avg
$19.07
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 11.49M | 148.13M | 155.08M |
| Net Income | -102,955,947 | 34.83M | 38.64M |
| Profit Margin | -896.1% | 23.5% | 24.9% |
| EBITDA | -118,235,029 | 58.57M | 58.31M |
| Free Cash Flow | — | 41.37M | 59.47M |
| Rev Growth | — | -6.9% | -7.9% |
| Debt/Equity | 0.01 | 0.90 | 0.74 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |